510(k) Report

FDA applicant

Immunalysis Corporation

Pomona, CA50 decisions1978–20251 recall

FDA records 50 decisions for Immunalysis Corporation (Pomona, CA) from 1978 to 2025: 50 510(k) clearances. Most are in product codes DJG (Enzyme Immunoassay, Opiates) and LAT (Radioimmunoassay, Cannabinoid (S)). Since 2016 its 510(k)s took a median of 380 days from receipt to decision, against 101 for FDA’s reviews in the same codes and years. Its devices cite 29 predicates, 5 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Immunalysis Corporation’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2014: 22015: 82016: 32017: 12018: 12019: 32020: 12021: 32023: 22025: 1
2007high 8 (2015) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2017

2017: 1
2007high 1 (2017) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Immunalysis Corporation by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Immunalysis Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report